Skip Navigation LinksOropouche-PCR

Viral and Rickettsial Disease Laboratory

Test Order
​Oropouche Virus Detection - PCR ​​

Information CategoryInformation Detail​​​
Pre-ApprovalContact VRDL.Submittal@cdph.ca.gov for pre-approval. ​​Please provide all of the supplemental information requested for a complete and accurate assessment.
Supplemental Information Requested
  • Travel location(s)
    • ​​Please note any travel to an area with documented or suspected Oropouche virus circulation within two weeks of initial symptom onset (as patients may experience recurrent symptoms).
    • Use CDC Oropouche in the Americas webpage to review areas with reported cases of Oropouche.​
  • Travel dates
  • Symptom onset date​​
    • ​​Please include earliest onset date. If the patient experienced a relapse, then please list:

      1. ​​date of initial symptom resolution

      2. date of recurrence

  • ​Symptoms
    • ​Please list all known symptoms associated with this illness.

    • Please note whether the patient experienced any abrupt onset of:

      • fever
      • headache​​​​​​
      • myalgia
      • arthralgia
      • photophobia
      • retroorbital/eye pain
      • signs and symptoms of neuroinvasive disease (e.g., stiff neck, altered mental status, seizures, limb weakness, or cerebrospinal fluid pleocytosis)
  • Co-morbidities
  • Immunocompromising medications
  • ​Pregnancy status
    • Please include gestational age or estimated date of delivery.
  • Dates and results of previous testing for other arboviruses, in particular dengue virus.
  • All specimen type(s) available
Submittal FormSpecimens must be accompanied with a hard copy of the completed VRDL General Purpose Specimen Submittal Form (PDF) or a form generated in the VRDL Lab Web Portal.
Methodology (Commercial Test Name or Laboratory Developed Test (LDT))Reverse transcription real time PCR (Surveillance use only)

Please note that specimens received at VRDL will be split: 0.5 mL will be sent to CDC for molecular testing.​​​


If specimen is collected 6–7 days post onset and tests RT-PCR negative, an aliquot will be sent to CDC for serological testing.​
Reflex TestingNone
Acceptable Specimen Type(s) and Collection Method

Human specimens:

  • Serum:
    • ​​​​Plain Red-Top Tubes: Serum collected in plain, red-top tubes must be separated and transferred to sterile, screw-cap tubes for storage and transport.
    • Serum Separator Tubes (SST): SST may be transported after centrifugation.
Minimum Volume Requested
  • Serum: 1 mL​
Transport Medium (if applicable)Not Applicable
Specimen LabelingEach specimen tube must be labeled with at least two unique patient identifiers, e.g., patient full name and date of birth.
Storage & Preservation of Specimen / Shipping Conditions
  • Separated Serum: Refrigerate or freeze separated serum promptly after collection.
  • Serum Separator Tubes: Refrigerate, do not freeze.

Ship refrigerated specimens to VRDL on cold packs. Ship frozen specimens to VRDL on dry ice.

Shipping Instructions

 

Work with your local public health department to ensure samples are packaged according to instructions for Biological Substance – Category B (UN 3373) shipment.

Ship specimens and a hard copy of the completed submittal forms to:    

CDPH VRDL

ATTN: Specimen Receiving

850 Marina Bay Parkway

Richmond, CA 94804

Phone: 510-307-8585

Turnaround Time10 Business Days
LimitationsNegative result does not preclude the possibility of infection.
Additional Information

Specimens should be collected as close to illness onset as possible and no longer than 7 days after onset unless timing of onset is unclear.
VRDL Points of ContactMedical and Epidemiology Liaisons: (510) 307-8585 or VRDL.submittal@cdph.ca.gov
​​​
Page Last Updated :